Question to the Department for Business, Energy and Industrial Strategy:

To ask the Secretary of State for Business, Energy and Industrial Strategy, what the planned increase in production is of the AstraZeneca covid-19 vaccine for UK use by March 2021.

The Government has invested over £300 million to scale up the UK’s manufacturing capabilities. Vaccines are the way out of this pandemic and vaccine supplies are part of our critical national infrastructure. Vaccines are a precious resource in very high demand across the world; therefore, for security reasons, it is not possible to provide detail about the size of our supplies and exact detail about deliveries.

We remain in close contact with all vaccine suppliers to ensure we can hit our target of offering vaccinations to priority groups 1 to 4, as advised by the Joint Committee on Vaccination and Immunisation, by 15 February 2021.